Glaukos (GKOS)
(Delayed Data from NYSE)
$135.39 USD
+0.13 (0.10%)
Updated Aug 28, 2024 04:00 PM ET
After-Market: $135.39 0.00 (0.00%) 7:46 PM ET
3-Hold of 5 3
D Value D Growth D Momentum F VGM
Brokerage Reports
0 items in cart
Glaukos Corporation [GKOS]
Reports for Purchase
Showing records 101 - 120 ( 128 total )
Company: Glaukos Corporation
Industry: Medical - Instruments
Solid 2017 Start on 1Q Beat, 2017 Guidance Raise
Provider: Roth Capital Partners, Inc.
Analyst: LEWIS C
Company: Glaukos Corporation
Industry: Medical - Instruments
Making Glaucoma Great Again - Management Travels Reaffirm Bullish Outlook
Provider: Roth Capital Partners, Inc.
Analyst: LEWIS C
Company: Glaukos Corporation
Industry: Medical - Instruments
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.
Company: Glaukos Corporation
Industry: Medical - Instruments
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.
Company: Glaukos Corporation
Industry: Medical - Instruments
Company: Glaukos Corporation
Industry: Medical - Instruments
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.
Company: Glaukos Corporation
Industry: Medical - Instruments
4Q Beat and Strong 2017 Growth Outlook Tops Expectations - Reiterate Buy
Provider: Roth Capital Partners, Inc.
Analyst: LEWIS C
Company: Glaukos Corporation
Industry: Medical - Instruments
Healthcare - Med Tech Preannouncement Watch - Look for News into Next Week?s JPM Conference
Provider: Roth Capital Partners, Inc.
Analyst: LEWIS C
Company: Glaukos Corporation
Industry: Medical - Instruments
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.
Company: Glaukos Corporation
Industry: Medical - Instruments
Novitas 2017 Schedule Confirms No Change for iStent - Removes Uncertainty
Provider: Roth Capital Partners, Inc.
Analyst: LEWIS C
Company: Glaukos Corporation
Industry: Medical - Instruments
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.
Company: Glaukos Corporation
Industry: Medical - Instruments
Company: Glaukos Corporation
Industry: Medical - Instruments
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.
Company: Glaukos Corporation
Industry: Medical - Instruments
Final 2017 CMS Rule Confirms Significant iStent Facility Fee Increases
Provider: Roth Capital Partners, Inc.
Analyst: LEWIS C
Company: Glaukos Corporation
Industry: Medical - Instruments
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.
Company: Glaukos Corporation
Industry: Medical - Instruments
Company: Glaukos Corporation
Industry: Medical - Instruments
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.
Company: Glaukos Corporation
Industry: Medical - Instruments
Sales Momentum Continues with 2Q Beat and 2016 Raise - Reiterate Buy
Provider: Roth Capital Partners, Inc.
Analyst: LEWIS C
Company: Glaukos Corporation
Industry: Medical - Instruments
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.
Company: Glaukos Corporation
Industry: Medical - Instruments
Proposed 2017 CMS Rates Indicate Meaningful Reimbursement Hike for iStent
Provider: Roth Capital Partners, Inc.
Analyst: LEWIS C